Search clinical trials for: Focal Epilepsy

Total 3727 results

Biogen

Completed

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy (OPUS)

Epilepsy, Focal Seizures, Partial Seizures

United States
Great Ormond Street Hospital for Children NHS Foundation...

Active, not recruiting

Novel Network Analysis of Intracranial Stereoelectroencephalography (NNAIS)

Epilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, Focal

United Kingdom
NYU Langone Health

Completed

A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

Epilepsy | Tuberous Sclerosis Complex | Focal Cortical Dysplasia

United States
NYU Langone Health
The Epilepsy Study Consortium

Completed

The Human Epilepsy Project (HEP)

Focal Epilepsy

United States, Canada, Australia
Yonsei University

Completed

A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)

Epilepsy and Focal Cortical Dysplasia II

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Terminated

Cognitive Impact of Benzodiazepin Withdrawn After Curative Epilepsy Surgery in Children With Focal Epilepsy (COGNIBENZO)

Cognitive Impact of Antiepileptic Drugs

France
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

Epilepsy | Focal-Onset Seizure

China
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice

Focal Epilepsy
Neuroelectrics Corporation
Beth Israel Deaconess Medical Center; Boston Children's Hospital

Completed

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

Refractory Epilepsy

United States
NaviFUS Corporation
Taipei Veterans General Hospital, Taiwan

Completed

Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy

Drug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant Epilepsy

Taiwan
Second Affiliated Hospital, School of Medicine,...
Qiushi Academy for Advanced Studies, Zhejiang University

Unknown

Mechanism Study of tDCS on Human Electrophysiological Network Via SEEG

Depression

China
Chinese University of Hong Kong

Unknown

Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong

Generalized Epilepsy | Focal Epilepsy | Partial Seizures, Simple

Hong Kong
Seoul National University Hospital
Dongsan Medical Center; Konkuk University

Completed

Efficacy and Safety of Rapid Titration Protocols of Lacosamide

Focal Epilepsy

Korea, Republic of
UCB Japan Co. Ltd.

Completed

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Epilepsy | Partial-onset Seizures

Japan
Hospices Civils de Lyon

Unknown

Cortical Excitability Assessment Using Paired Pulses (PP)

Focal Epilepsy

France
Johns Hopkins University

Terminated

Ultra High Field MRI of Focal Pediatric Epilepsy

Epilepsy

United States
Eisai GmbH

Completed

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Focal Epilepsy

Germany
University Hospital, Lille

Unknown

National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug (ENERGY)

Focal Epilepsy | Epilepsy Intractable

France
University Hospital, Strasbourg, France

Unknown

Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia (SPREAD)

Focal Epilepsy | Refractory Epilepsy | Focal Cortical Dysplasia

France
UCB Biopharma S.P.R.L.
PRA Health Sciences

Completed

A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Highly Drug-resistant Focal Epilepsy

Belgium, Bulgaria, Germany, Hungary, Netherlands, Spain
Hospices Civils de Lyon

Completed

Brain Maturation in Children With Localization Related Epilepsy (DYNAMAT)

Benign Childhood Epilepsy With Centro-temporal Spikes (BCECTS) | Focal Cryptogenic Epilepsy of Childhood | Cryptogenic Epilepsy of Childhood

France
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy (ELEC3D)

Focal Epilepsy

France
The Cooper Health System
Lundbeck LLC

Terminated

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Epilepsy | Epilepsia Partialis Continua | Kojewnikov's Epilepsy

United States
NYU Langone Health

Withdrawn

Turmeric as Treatment in Epilepsy

Epilepsy | Tuberous Sclerosis | Dravet Syndrome | Focal Seizures | Lennox-Gastaut Syndrome

United States
Dartmouth-Hitchcock Medical Center
American Epilepsy Society

Completed

Imaging Neuroinflammation in Epilepsy With Ferumoxytol MRI (IRONMAN)

Epilepsy

United States
Sunovion

Withdrawn

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Epilepsy

United States
Oslo University Hospital

Completed

Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy

Epilepsy | Generalized Epilepsy | Focal Epilepsy

Norway
Mid-Atlantic Epilepsy and Sleep Center, LLC
Eisai Inc.

Terminated

Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.

Epilepsy

United States
Assistance Publique Hopitaux De Marseille

Unknown

Depression, Stress and Vulnerability Factors in Drug Resistant Focal Epilepsies

Depression and Epilepsy

France
American Academy of Neurology
Forest Laboratories

Completed

Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?

Epilepsy

United States
Pavel Klein
H. Lundbeck A/S

Unknown

Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy

Epilepsy

United States
The Cleveland Clinic
UCB Pharma

Completed

Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy

Partial Epilepsy

United States
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
Lawson Health Research Institute
UCB Pharma GmbH

Terminated

Lacosamide IV and EEG/EKG (LIVE) Study (LIVE)

Focal Epilepsy

Canada
University Hospital, Strasbourg, France

Unknown

Interest Balance Auto-immune Population in Patients With Focal Epilepsy of Unknown Cause, Not Structural, Not Genetics, Newly Diagnosed (IBADEPIF)

Epilepsy

France
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Epilepsy | Partial Onset Seizures

Japan
AstraZeneca
Ardea Biosciences, Inc.

Completed

A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients

Gout and Asymptomatic Hyperuricemia

Japan
UCB Pharma

Completed

A Study of Brivaracetam in Subjects With Partial Onset Seizures

Epilepsy, Focal

France, Poland, United Kingdom, Belgium, Germany, Spain, Czech Republic, Finland, Netherlands
Mayo Clinic

Completed

Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy

Focal Epilepsy

United States
Mayo Clinic

Completed

Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy

Epilepsy

United States
Yonsei University

Completed

The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study

Focal Epilepsy

Korea, Republic of
Eisai GmbH

Terminated

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Epilepsy

Germany
University of Washington

Completed

Cefpodoxime vs Ciprofloxacin for Acute Cystitis

Urinary Tract Infection

United States
The Hospital for Sick Children

Completed

Determining the Extent of Diffusion Tensor Abnormalities in Focal Cortical Dysplasia (FCP)

Epilepsy | Focal Cortical Dysplasia

Canada
Atlantic University
A.T. Still University of Health Sciences

Completed

Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy

Partial Epilepsy | Focal Onset Epilepsy

United States
SK Life Science, Inc.

Completed

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Epilepsy | Epilepsies, Partial | Epilepsy, Complex Partial | Complex Partial Seizures
SK Life Science, Inc.

Completed

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Epilepsy, Complex Partial | Epilepsy, Partial, Motor | Epilepsy, Simple Partial | Focal Motor Epilepsy
California Pacific Medical Center Research Institute
Genentech, Inc.

Completed

A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis

Chronic Focal Encephalitis | Rasmussen's Encephalitis

United States
Johannes Gutenberg University Mainz
UCB Pharma GmbH

Completed

Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs (STEP-ONE)

Focal Epilepsy

Germany
SK Life Science, Inc.

Completed

A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

Epilepsy, Complex Partial | Epilepsy, Partial, Motor | Epilepsy, Simple Partial | Focal Motor Epilepsy

Search clinical trials for: Focal Epilepsy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations